Gender Disparity between Cutaneous and Non-Cutaneous Manifestations of Lyme Borreliosis

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Strle, Franc ^a   Wormser, Gary P ^b   Mead, Paul ^c   Dhaduvai, Kanthi ^b   Longo, Michael V ^b   Adenikinju, Omosalewa ^b   Soman, Sandeep ^b   Tefera, Yodit ^b   Maraspin, Vera ^a   Lotrič Furlan, Stanka ^a   Ogrinc, Katarina ^a   Cimperman, Jože ^a   Ružić Sabljić, Eva ^d   Stupica, Daša ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ACRODERMATITIS CHRONICA ATROPHICANS; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL FEATURE; CONCURRENT INFECTION; CONTROLLED STUDY; DERMATITIS; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SLOVENIA; SYNOVIAL FLUID; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; SEX DISTRIBUTION; SKIN DISEASES; SLOVENIA; YOUNG ADULT;

EID: 84878474044     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064110     Document Type: Article

References (47)

1. Stanek G, Wormser GP, Gray J, Strle F, (2012) Lyme borreliosis. Lancet 379: 461-473.
2. Bacon RM, Kugeler KJ, Mead PS, (2008) Surveillance for Lyme disease - United States, 1992-2006. Morbidity Mortality Weekly Report (MMWR) 57 (SS10) (): 1-9.
3. Wormser GP, Shapiro ED, (2009) Implications of gender in chronic Lyme disease. J Womens Health 18: 831-834.
4. Fulop B, Poggensee G, (2008) Epidemiological situation of Lyme borreliosis in Germany: surveillance data from six eastern German states, 2002 to 2006. Parasitol Res 103: S117-S120.
5. Mehnert WH, Krause G, (2005) Surveillance of Lyme borreliosis in Germany, 2002 and 2003. Eurosurveillance 10: 83-85.
6. Institute of Public Health of the Republic of Slovenia. Epidemiologic surveillance of communicable diseases in Slovenia in 2010. Ljubljana, 2011. Available: http://www.ivz.si. Accessed 2013 Mar 12.
7. Centers for Disease Control and Prevention (CDC) website. Available: http://wwwn.cdc.gov/nndss/document/2012_Case%20Definitions.pdf. Accessed 2013 Mar 12.
8. Wilske B, Schierz G, Preac-Mursic V, Weber K, Pfister HW, et al. (1984) Serological diagnosis of erythema migrans disease and related disorders. Infection 5: 331-337.
9. Strle F, Stanek G, (2009) Clinical manifestations and diagnosis of Lyme borreliosis. Curr Probl Dermatol 37: 51-110.
10. Marangoni A, Moroni A, Accardo S, Cevenini R, (2008) Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 27: 349-354.
11. Reiber H, Peter JB, (2001) Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184: 101-122.
12. Statistical Office of the Republic of Slovenia website. Available: http://www.stat.si/eng/index.asp. Accessed 2013 Feb 28.
13. Selvin S (1991) Statistical Analysis of Epidemiological Data. New York: Oxford University Press. pp. 375.
14. Woolson RF, Bean JA, (1982) Mantel-Haenszel statistics and direct standardization. Statistics in Medicine 1: 37-39.
15. Asbrink E, (1993) Acrodermatitis chronica atrophicans. Clin Dermatol 11: 369-375.
16. Brehmer-Andersson E, Hovmark A, Asbrink E, (1998) Acrodermatitis chronica atrophicans: histopathologic findings and clinical correlations in 111 cases. Acta DermVenereol 78: 207-213.
17. Hulshof MM, Vandenbroucke JP, Nohlmans LMKE, Spanjaard L, Bavinck JNB, et al. (1997) Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans. Arch Dermatol 133: 33-37.
18. Tibbles CD, Edlow JA, (2007) Does this patient have erythema migrans? JAMA 297: 2617-2627.
19. Bennet L, Halling A, Berglund J, (2006) Increased incidence of Lyme borreliosis in Southern Sweden following mild winters and during warm, humid summers. Eur J Clin Microbiol Infect Dis 25: 426-432.
20. Marangoni A, Sambri V, Accardo S, Carvini F, Mondardini V, et al. (2006) A decrease in the immunoglobulin G antibody response against VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease. Clin Vaccine Immunol 13: 525-529.
21. Bennet L, Stjernberg L, Berglund J, (2007) Effect of gender on clinical and epidemiologic features of Lyme borreliosis. Vector-Borne Zoonotic Dis 7: 34-41.
22. Bennet L, Berglund J, (2002) Re-infection with Lyme borreliosis: A retrospective follow-up study in Southern Sweden. Scand J Infect Dis 34: 183-186.
23. Jarefors S, Bennet L, You E, Forsberg P, Ekerfelt C, et al. (2006) Lyme borreliosis reinfection: might it be explained by a gender difference in immune response. Immunology 118: 224-232.
24. Renaud I, Cachin C, Gerster JC, (2004) Good outcomes of Lyme arthritis in 24 patients in an endemic area of Switzerland. Joint Bone Spine 71: 39-43.
25. Berglund J, Hansen BU, Eitrem R, (1995) Lyme arthritis - a common manifestation in a highly endemic area in Sweden. J Rheumatol 22: 695-701.
26. Pancewicz S, Popku J, Rutkowski R, Knaś M, Grygorczuk S, et al. (2009) Activity of liposomal exoglycosidoses in serum and synovial fluid in patients with chronic Lyme and rheumatoid arthritis. Scand J Infect Dis 41: 584-589.
27. Luczaj W, Moniuszko A, Rusak M, Pancewicz S, Zajkowska J, et al. (2011) Lipid peroxidation products as potential bio-indicators of Lyme arthritis. Eur J Clin Microbiol Infect Dis 30: 415-422.
28. Kirchner A, Koedel W, Fingerle V, Paul R, Wilske B, et al. (2000) Up-regulation of matrix metalloproteinase-9 in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis. J Neurol Neurosurg Psych 68: 368-371.
29. Van Burgel ND, Brandenburg A, Gerritsen HJ, Kroes ACM, Van Dam AP, (2011) High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients. Clin Microbiol Infect 17: 1495-1500.
30. Ljostad U, Skogvall E, Eikeland R, Midgard R, Skarpaas T, et al. (2008) Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomized trial. Lancet Neurol 7: 690-695.
31. Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, et al. (1999) Comparison of culture-confirmed erythema mirgans caused by Borrelia burgdorferi sensu stricto in New York state and by Borrelia afzelii in Slovenia. Ann Intern Med 130: 32-36.
32. Logar M, Ružić-Sabljić E, Lotrič-Furlan S, Cimperman J, Jurca T, et al. (2004) Comparison of erythema migrans caused by Borrelia afzelii and Borrelia garinii. Infection 32: 15-19.
33. Cerar D, Cerar T, Ružić-Sabljić E, Wormser GP, Strle F, (2010) Subjective symptoms after treatment of early Lyme disease. Am J Med 123: 79-86.
34. Stupica D, Lusa L, Ružić-Sabljić E, Cerar T, Strle F, (2012) Treatment of erythema migrans with doxycycline for 10 days versus 15 days. Clin Infect Dis 55: 343-350.
35. Strle F, Ružić-Sabljić E, Logar M, Maraspin V, Lotrič-Furlan S, et al. (2011) Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector Borne Zoonotic Dis 11: 1253-1258.
36. Wormser GP, Brisson D, Liveris D, Hanincová K, Sandigursky S, et al. (2008) Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis 198: 1358-1364.
37. Brisson D, Baxamusa N, Schwartz I, Wormser GP, (2011) Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients. PLoS One 6 (8) (): e22926.
38. Panelius J, Rank A, Meri T, Seppala I, Meri S, (2010) Expression and sequence diversity of the complement regulating outer surface protein E in Borrelia afzelii vs. Borrelia garinii in patients with erythema migrans or neuroborreliosis. Microbiol Pathogenesis 49: 363-368.
39. Alitalo A, Meri T, Comstedt P, Jeffery L, Tornberg J, et al. (2005) Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis. Eur J Immunol 35: 3043-3053.
40. Institute of Public Health of the Republic of Slovenia website. Available: ZUBSTAT http://www.ivz.si/. Accessed 2012 Nov 10.
41. Benoit VM, Petrich A, Alugupalli KR, Marty-Roix R, Moter A, et al. (2010) Genetic control of the innate immune response to Borrelia hermsii influences the course of relapsing fever in inbred strains of mice. Infect Immun 78: 586-594.
42. Raoult D, Tissot-Dupont H, Foucault C, Gouvernet J, Fournier PE, et al. (2000) Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine 79: 109-123.
43. Leone M, Honstettre A, Lepidi H, Capo C, Bayard F, et al. (2004) Effect of sex on Coxiella burnetii infection: protective role of 17 beta-estradiol. J Infect Dis 189: 339-345.
44. Huaux JP, Bigaignon G, Stadtsbaeder S, Zangerle PF, De Deuxchaisnes CN, (1988) Pattern of Lyme arthritis in Europe: report of 14 cases. Ann Rheum Dis 47: 164-165.
45. Pietruczuk A, Swierzbinska R, Pancewicz S, Pietruczuk M, Hermanowska-Szpakowicz T, (2006) Serum levels of interleukin-18 (IL-18), interleukin 1-beta (IL-1beta), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with Lyme arthritis. Infection 34: 158-162.
46. Karkkonen K, Stiernstedt SH, Karlsson M, (2001) Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand J Infect Dis 33: 259-262.
47. Ciceroni L, Ciarrochi S, Ciervo A, Mondarini V, Guzzo F, et al. (2001) Isolation and characterization of Borrelia burgdorferi sensu lato strains in an area of Italy where Lyme borreliosis is endemic. J Clin Microbiol 39: 2254-2260.